Pharma-Planta is an EU Sixth Framework Program integrated project whose aim is to develop an approved production pipeline for pharmaceutical proteins made in plants, and take a candidate product all the way through development culminating in a phase I human clinical trial.
The Pharma-Planta Consortium comprises 40 groups representing 33 partner organizations from 12 European countries and South Africa. The organizations currently participating in the consortium are, a mixture of academic partners, SMEs and large industry partners.
